大行評級|建銀國際:上調百濟神州目標價至175港元 預期第三季業績將令人鼓舞
建銀國際發表研報指,預期百濟神州將公佈令人鼓舞的2024財年第三季業績。該行指,基於百濟神州的BTK藥物澤布替尼正將血癌相關適應症的區域覆蓋範圍,擴大到更多海外國家,故預計澤布替尼在第三季度的銷售額將按年增長94%或按季增長9%至6.95億美元。建銀國際亦預期,百濟神州第三季度總營收將按年升26%或按季將升6%至9.82億美元。假設2025及2026財年公司生產效率提高,混合毛利率預測將分別提高2.1及3.5個百分點,推動公司毛利率在2025及2026財年分別達到85.9%及86.1%。考慮到市場情緒改善,建銀國際將百濟神州H股目標價由141港元上調至175港元,維持“跑贏大市”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.